Prognostic implication of SYT-SSX fusion type in synovial sarcoma: A multi-institutional retrospective analysis in Japan
Satoshi Takenaka(Osaka International Cancer Institute), Hideki Yoshikawa(Amita Health), Akira Myoui(Osaka University Hospital), Junya Toguchida(Kyoto University), Yukihide Iwamoto(Kyushu University), Makoto Ieguchi(Osaka City University), Nobuyuki Hashimoto(Osaka Gakuin University), Ikuo Kudawara(Mie University), Kazuhiro Tanaka(Oita University), Yasuaki Aoki(Himeji Red Cross Hospital), Mitsunori Kaya, Akihiko Matsumine(University of Fukui), Takafumi Ueda(The University of Osaka), Nobuhito Araki(Mie University), Takuro Wada(Sapporo Medical University), Tomitaka Nakayama(Kyoto University), Norifumi Naka(University of the Witwatersrand), Ichiro Baba(Osaka Medical and Pharmaceutical University), Atsumasa Uchida(Mie University), Toshifumi Ozaki(Okayama University)
Cited by 60
Related Papers
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Osteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study Group
|Journal of Clinical Oncology|2003|343
Osteosarcoma of the spine
|Cancer|2002|282
Percutaneous radiofrequency ablation in osteoid osteoma
|Journal of Bone and Joint Surgery - British Volume|2001|267